Ring Pharma SA
The score of Ring Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -44 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ring Pharma's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Apr 2026
- Year ended 30 Sep 2024filed on 25 Apr 2025
- Year ended 30 Sep 2023filed on 29 Apr 2024
- Year ended 30 Sep 2022filed on 28 Apr 2023
- Year ended 30 Sep 2021filed on 28 Apr 2022
Ring Pharma's financial analysis
- Solvency-0.2%sector median: 60.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ring Pharma
Ring Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0472.540.052
- VAT number
- BE0472540052
- Peppol
- Registered · 0208:0472540052 · as of 02 Nov 2026
- Legal form
- SA
- Incorporated
- 07 Aug 2000
- Registered office
- 1850 Grimbergen
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Market research and public opinion polling (NACE 73200)
Ring Pharma (SA) has been based in Grimbergen since 2000, active in: market research and public opinion polling. For 2025, it reports a net loss of 104,944 € and equity of −2,412 €; its revenue is not published. Its solvency stands at -0.2%, below the median of its sector (60.9%).
Companies similar to Ring Pharma
Companies in the same business, of comparable size and area, outside its group.
- Keystone Network International Market research and public opinion polling Grimbergen · balance sheet €1.51m
- Mattinvest Market research and public opinion polling Ixelles · balance sheet €1.44m
- Admara Market research and public opinion polling Saint-Gilles · balance sheet €1.36m
- Hidden Horizons Market research and public opinion polling Etterbeek · balance sheet €1.10m
- Sgvh Consulting Market research and public opinion polling Lasne · balance sheet €1.91m
- Icona Market research and public opinion polling Dinant · balance sheet €2.30m
- Nova - TEC Market research and public opinion polling Ixelles · balance sheet 950,958 €
- SeedGrowth Europe Business and other management consultancy activities Watermael-Boitsfort · balance sheet 425,166 €
Frequently asked questions about Ring Pharma
What is the revenue of Ring Pharma?
Ring Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ring Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0472540052 for Ring Pharma, if the company is VAT-registered. Its company number (CBE) is 0472.540.052.
Where is the registered office of Ring Pharma?
According to the CBE register, the registered office of Ring Pharma is in 1850 Grimbergen.
What is the equity of Ring Pharma?
At the close of the 2025 financial year, the equity of Ring Pharma amounts to -2,412 €, a solvency of -0.2% of total assets.
Who manages Ring Pharma?
The register lists 2 active mandates at Ring Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ring Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →